Cross-reactive immunogenicity of group A streptococcal vaccines designed using a recurrent neural network to identify conserved M protein linear epitopes
- 1 March 2021
- Vol. 39 (12) , 1773-1779
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 31 references indexed in Scilit:
- Factor H Binds to the Hypervariable Region of Many Streptococcus pyogenes M Proteins but Does Not Promote Phagocytosis Resistance or Acute VirulencePLOS Pathogens, 2013
- New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococciVaccine, 2011
- Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopesVaccine, 2010
- Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccinesBMC Bioinformatics, 2007
- High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunityVaccine, 2004
- Rapidly fatal necrotising fasciitis caused by Streptococcus pyogenes.Journal of Clinical Pathology, 1993
- Immunogenicity in mice of tandem repeats of an epitope from herpes simplex gD protein when expressed by recombinant adenovirus vectorsVaccine, 1993
- Protective immunogenicity and T lymphocyte specificity of a trivalent hybrid peptide containing NH2-terminal sequences of types 5, 6, and 24 M proteins synthesized in tandem.Journal of Experimental Medicine, 1987
- Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein.Journal of Experimental Medicine, 1986
- Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein.Journal of Experimental Medicine, 1979